Increased IL-17A but Decreased IL-27 Serum Levels in Patients with Multiple Sclerosis

Authors

  • Behzad Baradaran Department of Immunology, Faculty of Medicine | Immunology Unit, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Leila Aghebati Department of Immunology, Faculty of Medicine
  • Mehdi Farhoodi Neuroscience Research Center
  • Mohamadreza Bonyadi Department of Immunology, Faculty of Medicine | Immunology Unit, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  • Reza Khajir Yeganeh Department of Immunology, Faculty of Medicine
  • Zohreh Babaloo Department of Immunology, Faculty of Medicine | Neuroscience Research Center | Immunology Unit, Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
Abstract:

Background: Effector CD4+ T cell subsets play an important role in Multiple Sclerosis (MS). Interleukin-27 (IL-27) suppresses Th (Th1, Th2 and Th17) cells and dampens autoimmunity and tissue inflammation by promoting the generation of Type 1 regulatory T cells (Tr1). Objective: To identify the relative levels of IL-27 and IL-17A in MS disease. Method: In a case-control study, venous blood was collected from forty MS patients and forty-three healthy subjects as control group. Serum levels of IL-27 and IL-17A were measured by ELISA method. Results: A significant difference between serum IL-17A concentration in patients (120.68 ± 209.85 pg/ml) and control group (67.26 ± 117.76 pg/ml, p=0.016) was found. Serum IL-27 levels of the MS patients (159.7 ± 581.4 pg/ml) were significantly lower than control subjects (180.35 ± 507.84 pg/ml, p=0.001). Conclusion: Our findings show decreased levels of IL-27 against increasing IL-17A levels in patients group which may suggest the suppressive role of IL-27 on inflammatory process of MS.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

increased il-17a but decreased il-27 serum levels in patients with multiple sclerosis

background: effector cd4+ t cell subsets play an important role in multiple sclerosis (ms). interleukin-27 (il-27) suppresses th (th1, th2 and th17) cells and dampens autoimmunity and tissue inflammation by promoting the generation of type 1 regulatory t cells (tr1). objective: to identify the relative levels of il-27 and il-17a in ms disease. method: in a case-control study, venous blood was c...

full text

Decreased serum IL-7 levels in patients with systemic sclerosis.

Sirs, Interleukin-7 (IL-7) was originally defined as a pre-B lymphocyte growth factor and was subsequently found to augment the growth of T lymphocytes. A recent study showed that IL-7 is an anti-fibrogenic factor in pulmonary fibrosis in vitro. In this study, we determined the serum levels of IL-7 in patients with SSc. Forty-three patients with SSc and 28 healthy controls were included in the ...

full text

Increased Serum Levels of IL-17A and IL-23 Are Associated with Decreased Vitamin D3 and Increased Pain in Osteoarthritis

INTRODUCTION Osteoarthritis (OA) is the most common type of arthritis and proinflammatory cytokines have been considered as the main etiologic factor in the pathogenesis of the disease. Serum levels of cytokines, that are associated with innate immunity and TH1 cells, have been analyzed in OA patients, however, there is limited research that profiles cytokines associated with Th17 cells and the...

full text

Serum levels of IL-17A increase in Asthma but not in accordance with Serum level of IgE and Asthma Severity

Background and Aims: Recent evidence suggests that T helper (Th) 17 cells are involved in the emergence of asthma. Th17 cells have a key role in inducing inflammation in asthmatic airways thus Interleukin (IL)-17A, the main cytokine of Th17, contributes to airways inflammation. Materials and Methods: We evaluated the level of IL-17A and total immunoglobulin E (IgE) in sera of 100 asthmatic p...

full text

The association of IL-17A polymorphisms with IL-17A serum levels and risk of ischemic stroke

The aim of our study was to investigate the association of interleukin-17A (IL-17A) polymorphisms with IL-17A serum levels and risk of ischemic stroke (IS) in a Chinese population. 392 IS patients and 443 controls were included in this study. The polymorphisms of IL-17A gene were determined by Snapshot SNP genotyping assay and DNA sequencing. Serum IL-17A levels were measured by enzyme-linked i...

full text

P37: Decreased Serum Levels of Interleukin-35 Among Patients with Relapsing Remitting Multiple Sclerosis

The regulatory role of interleukin-35 (IL-35) in the immunopathogenesis of multiple sclerosis (MS) is suggested in very few studies. We aimed to measure serum levels of IL-35 among clinically isolated syndrome (CIS) and relapsing-remitting MS (RRMS) patients and evaluate the associations between this cytokine and the disease clinical course. This cross-sectional study was conducted during 2017 ...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 10  issue 1

pages  47- 54

publication date 2013-03-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023